Our team
A board with deep oncolytic virus, vaccine and public-company experience, supported by external scientific consultants who bring specialist expertise to TollCyto's programmes.
Director · MD PhD
Clinician-scientist and Professor of Medical Oncology at the University of Surrey. Practising oncologist at St Luke's Cancer Centre and the Surrey/Sussex Cancer Network.
Director · PhD
Emeritus Professor of Microbiology and Disease Intervention at the University of Surrey. Research scientist with a track record in vaccine design and development.
Director
Fellow Chartered Accountant with 30+ years of international financial, corporate and public company experience. Proven track record working with growth companies.
Scientific Consultants
Specialist scientific consultants who contribute to TollCyto's research programmes alongside the board.
Scientific Consultant · DVM, PhD
Professor of Molecular Immunology at Queen's University, Kingston, Ontario. Internationally recognised expert in preclinical models of bladder cancer.
Scientific Consultant · PhD
Senior Research Fellow at the University of Surrey. Specialist in virology, oncolytic viruses, molecular biology, animal models, and cancer biomarkers. Inventor on TollCyto's patent family.
